MVP 2.22% 44.0¢ medical developments international limited

The big problem is what comes first share price or approval. I...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,033 Posts.
    lightbulb Created with Sketch. 317
    The big problem is what comes first share price or approval. I am a long term holder and well remember $11 briefly, $8 for quite awhile and thinking $6.50 wasn’t good enough so agree IF we get traction in a big market the price upside is huge.
    Finding a partner to front the regulatory costs and strike reasonable terms is going to be extremely difficult without a success story in another market outside of Australia. That is why I believe Europe was so important to either get a partner or show meaningful volume so that our share price could get back to where it traditionally was .
    At the moment we seem to be caught in the wilderness and I am not getting the sense that Board and Management have a clear plan to execute.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
44.0¢
Change
-0.010(2.22%)
Mkt cap ! $49.56M
Open High Low Value Volume
46.0¢ 46.0¢ 44.0¢ $61.85K 139.3K

Buyers (Bids)

No. Vol. Price($)
1 10442 44.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 313 2
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.